Hippocampal sclerosis in association with neurocysticercosis

Epileptic Disorders

Volumn 9, Issue 3, 2007, Pages 292-299

  Singla, Monika ^a   Singh, Parampreet ^b   Kaushal, Sandeep ^a   Bansal, Rajinder ^a   Singh, Gagandeep ^a  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Dual pathology; Epilepsy; Hippocampal sclerosis; Neurocysticercosis; Seizure

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CORTICOSTEROID; DEXAMETHASONE; ETHAMBUTOL; ISONIAZID; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; CYSTICERCUS; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; GRANULOMA; HIPPOCAMPAL SCLEROSIS; HUMAN; IMAGING; INTRACTABLE EPILEPSY; LUNG TUBERCULOSIS; MALE; MEDICAL RECORD REVIEW; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; TELEMETRY; TEMPORAL LOBE EPILEPSY;

ADULT; ANIMALS; CHILD, PRESCHOOL; COHORT STUDIES; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; FEMALE; HIPPOCAMPUS; HUMANS; INDIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; SCLEROSIS; SEIZURES; STATUS EPILEPTICUS; TAENIA SOLIUM; TELEMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35348960063     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: 10.1684/epd.2007.0122     Document Type: Article

References (22)

1. Alsaadi TM, Bateman LM, Laxer KD, et al. Potentially misleading extratemporal lobe lesions in patients with temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2003; 74: 566-9.
2. Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998; 39: 1025-40.
3. Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002; 59: 1730-4.
4. Cendes F, Cook MJ, Watson C, et al. Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology 1995; 45: 2058-64.
5. Chung CK, Lee SK, Chi JG. Temporal lobe epilepsy caused by intrahippocampal calcified cysticercus: a case report. J Korean Med Sci 1998; 13: 445-8.
6. da Gama CN, Kobayashi E, Li LM, et al. Hippocampal atrophy and neurocysticercosis calcifications. Seizure 2005; 14: 85-8.
7. DeGiorgio C, Pietsch-Escueta S, Tsang V, et al. Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA. Acta Neurol Scand 2005; 111: 84-8.
8. Del Brutto OH, Santibanez R, Noboa CA, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992; 42: 389-92.
9. Garcia HH, Gonzalez AE, Evans CA, et al. Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet 2003; 362: 547-56.
10. Garcia HH, Gilman R, Martinez M, et al. E. Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG). Lancet 1993; 341: 197-200.
11. Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 1969; 25: 295-330.
12. Kobayashi E, Guerreiro CA, Cendes F. Late onset temporal lobe epilepsy with MRI evidence of mesial temporal sclerosis following acute neurocysticercosis: case report. Arq Neuropsiquiatr 2001; 59: 255-8.
13. Leite JP, Terra-Bustamante VC, Fernandes RM, et al. Calcified neurocysticercotic lesions and postsurgery seizure control in temporal lobe epilepsy. Neurology 2000; 55: 1485-91.
14. Medina MT, Rosas E, Rubio-Donnadieu F, et al. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990; 150: 325-7.
15. Montano SM, Villaran MV, Ylquimiche L, et al. Cysticercosis Working Group in Peru. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 2005; 65: 229-33.
16. Morrell F. Secondary epileptogenesis in man. Arch Neurol 1985; 42: 318-35.
17. Ong S, Talan DA, Moran GJ, et al. Emergency ID Net Study Group. Neurocysticercosis in radiographically-imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002; 8: 608-13.
18. Rajshekhar V. Rate of spontaneous resolution of a solitary cysticercus granuloma in patients with seizures. Neurology 2001; 57: 2315-7.
19. Singh G, Singh P, Singh I, et al. Epidemiologic classification of seizures associated with neurocysticercosis: Observations from a sample of seizure disorders in neurological care in India. Acta Neurol Scand 2006; 113: 233-40.
20. Stringer JL, Marks LM, White Jr. AC, et al. P. Epileptogenic activity of granulomas associated with murine cysticercosis. Exp Neurol 2003; 183: 532-6.
21. Terra-Bustamante VC, Coimbra ER, Rezek KO, et al. Cognitive performance of patients with mesial temporal lobe epilepsy and incidental calcified neurocysticercosis. J Neurol Neurosurg Psychiatry 2005; 76: 1080-3.
22. Wichert-Ana L, Velasco TR, Terra-Bustamante VC, et al. Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis. Arch Neurol 2004; 61: 1117-9.